Cinemark's Dual Listing Announcement: Cinemark Holdings, Inc. has announced the dual listing of its common stock on NYSE Texas, enhancing its relationship with the New York Stock Exchange where it has been listed since 2007.
Significance of Texas Presence: The company emphasizes its strong presence in Texas, operating over 25% of its domestic theaters there, and aims to strengthen connections with the state through this new listing.
Leadership Statements: Sean Gamble, Cinemark's President and CEO, expressed excitement about the dual listing, highlighting opportunities for investors focused on regional markets and supporting Texas's financial ecosystem.
Company Overview: Cinemark, headquartered in Plano, TX, operates 497 theaters with 5,647 screens across 42 states and 13 countries, offering a premium moviegoing experience with various innovative services and amenities.
CNK
$23.81+Infinity%1D
Analyst Views on CNK
Wall Street analysts forecast CNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNK is 35.20 USD with a low forecast of 34.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast CNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNK is 35.20 USD with a low forecast of 34.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 23.830
Low
34.00
Averages
35.20
High
37.00
Current: 23.830
Low
34.00
Averages
35.20
High
37.00
Deutsche Bank
Buy
downgrade
$34 -> $32
2025-12-15
New
Reason
Deutsche Bank
Price Target
$34 -> $32
2025-12-15
New
downgrade
Buy
Reason
Deutsche Bank lowered the firm's price target on Cinemark (CNK) to $32 from $34 and keeps a Buy rating on the shares. The firm cites the emergence of Netflix (NFLX) competition following its purchase of Warner Bros. Discovery (WBD) and lower box office expectations for the recent pullback in the shares. If Paramount (PSKY) ends up being the acquiror of Warner Bros., Cinemark shares should see an "immediate recovery" back to the $28 range, the analyst tells investors in a research note. If Netflix remains the buyer, the stock could see downside to about $22.50, based on Deutsche's analysis. The firm, however, sees upside to $32 over the next 12 months for Cinemark shares, assuming no change to Warner's theatrical distribution. It believes Paramount seems the more likely buyer of Warner given its all cash offer for the entire company :with a high probability of closing."
JPMorgan
Overweight
downgrade
$38 -> $37
2025-11-06
Reason
JPMorgan
Price Target
$38 -> $37
2025-11-06
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Cinemark to $37 from $38 and keeps an Overweight rating on the shares. The company's reported a market share driven beat in Q3, the analyst tells investors in a research note.
Roth Capital
Eric Handler
Buy
maintain
$34 -> $35
2025-11-05
Reason
Roth Capital
Eric Handler
Price Target
$34 -> $35
2025-11-05
maintain
Buy
Reason
Roth Capital analyst Eric Handler raised the firm's price target on Cinemark to $35 from $34 and keeps a Buy rating on the shares after the company reported "strong outperformance" in a soft Q3 box office environment. Having paid off its pandemic related debt and reduced its net leverage, Cinemark has "significant financial flexibility" to reinvest in the business, return capital to shareholders, and explore M&A, the analyst tells investors.
Morgan Stanley
Overweight
downgrade
$35 -> $34
2025-10-21
Reason
Morgan Stanley
Price Target
$35 -> $34
2025-10-21
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Cinemark to $34 from $35 and keeps an Overweight rating on the shares. The 2025 box office looks to grow 5% year-over-year, which would be "healthy but below initial expectations," says the analyst. The firm's estimates remain "modestly above consensus" in 2026, but it is now taking a more conservative approach, the analyst added.
About CNK
Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
